EPAS1 Antibody Market - Global Outlook and Forecast 2022-2028

January 2022 | 72 pages | ID: EEB7BC289388EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of EPAS1 Antibody in Global, including the following market information:

Global EPAS1 Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global EPAS1 Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 95% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of EPAS1 Antibody include Thermo Fisher Scientific, R&D Systems, Lifespan Biosciences, Bio-Rad, Abbexa Ltd, Boster Bio, Atlas Antibodies, Biobyt and Novus Biologicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the EPAS1 Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global EPAS1 Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global EPAS1 Antibody Market Segment Percentages, by Type, 2021 (%)

• Above 95%
• Above 99%
• Others

Global EPAS1 Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global EPAS1 Antibody Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Global EPAS1 Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global EPAS1 Antibody Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies EPAS1 Antibody revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies EPAS1 Antibody revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• R&D Systems
• Lifespan Biosciences
• Bio-Rad
• Abbexa Ltd
• Boster Bio
• Atlas Antibodies
• Biobyt
• Novus Biologicals
• Aviva Systems Biology
• ProSci
• BioLegend

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 EPAS1 Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global EPAS1 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EPAS1 ANTIBODY OVERALL MARKET SIZE

2.1 Global EPAS1 Antibody Market Size: 2021 VS 2028
2.2 Global EPAS1 Antibody Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top EPAS1 Antibody Players in Global Market
3.2 Top Global EPAS1 Antibody Companies Ranked by Revenue
3.3 Global EPAS1 Antibody Revenue by Companies
3.4 Top 3 and Top 5 EPAS1 Antibody Companies in Global Market, by Revenue in 2021
3.5 Global Companies EPAS1 Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 EPAS1 Antibody Players in Global Market
  3.6.1 List of Global Tier 1 EPAS1 Antibody Companies
  3.6.2 List of Global Tier 2 and Tier 3 EPAS1 Antibody Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global EPAS1 Antibody Market Size Markets, 2021 & 2028
  4.1.2 Above 95%
  4.1.3 Above 99%
  4.1.4 Others
4.2 By Type - Global EPAS1 Antibody Revenue & Forecasts
  4.2.1 By Type - Global EPAS1 Antibody Revenue, 2017-2022
  4.2.2 By Type - Global EPAS1 Antibody Revenue, 2023-2028
  4.2.3 By Type - Global EPAS1 Antibody Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global EPAS1 Antibody Market Size, 2021 & 2028
  5.1.2 Biopharmaceutical Companies
  5.1.3 Hospitals
  5.1.4 Bioscience Research Institutions
  5.1.5 Others
5.2 By Application - Global EPAS1 Antibody Revenue & Forecasts
  5.2.1 By Application - Global EPAS1 Antibody Revenue, 2017-2022
  5.2.2 By Application - Global EPAS1 Antibody Revenue, 2023-2028
  5.2.3 By Application - Global EPAS1 Antibody Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global EPAS1 Antibody Market Size, 2021 & 2028
6.2 By Region - Global EPAS1 Antibody Revenue & Forecasts
  6.2.1 By Region - Global EPAS1 Antibody Revenue, 2017-2022
  6.2.2 By Region - Global EPAS1 Antibody Revenue, 2023-2028
  6.2.3 By Region - Global EPAS1 Antibody Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America EPAS1 Antibody Revenue, 2017-2028
  6.3.2 US EPAS1 Antibody Market Size, 2017-2028
  6.3.3 Canada EPAS1 Antibody Market Size, 2017-2028
  6.3.4 Mexico EPAS1 Antibody Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe EPAS1 Antibody Revenue, 2017-2028
  6.4.2 Germany EPAS1 Antibody Market Size, 2017-2028
  6.4.3 France EPAS1 Antibody Market Size, 2017-2028
  6.4.4 U.K. EPAS1 Antibody Market Size, 2017-2028
  6.4.5 Italy EPAS1 Antibody Market Size, 2017-2028
  6.4.6 Russia EPAS1 Antibody Market Size, 2017-2028
  6.4.7 Nordic Countries EPAS1 Antibody Market Size, 2017-2028
  6.4.8 Benelux EPAS1 Antibody Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia EPAS1 Antibody Revenue, 2017-2028
  6.5.2 China EPAS1 Antibody Market Size, 2017-2028
  6.5.3 Japan EPAS1 Antibody Market Size, 2017-2028
  6.5.4 South Korea EPAS1 Antibody Market Size, 2017-2028
  6.5.5 Southeast Asia EPAS1 Antibody Market Size, 2017-2028
  6.5.6 India EPAS1 Antibody Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America EPAS1 Antibody Revenue, 2017-2028
  6.6.2 Brazil EPAS1 Antibody Market Size, 2017-2028
  6.6.3 Argentina EPAS1 Antibody Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa EPAS1 Antibody Revenue, 2017-2028
  6.7.2 Turkey EPAS1 Antibody Market Size, 2017-2028
  6.7.3 Israel EPAS1 Antibody Market Size, 2017-2028
  6.7.4 Saudi Arabia EPAS1 Antibody Market Size, 2017-2028
  6.7.5 UAE EPAS1 Antibody Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific EPAS1 Antibody Major Product Offerings
  7.1.4 Thermo Fisher Scientific EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 R&D Systems
  7.2.1 R&D Systems Corporate Summary
  7.2.2 R&D Systems Business Overview
  7.2.3 R&D Systems EPAS1 Antibody Major Product Offerings
  7.2.4 R&D Systems EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.2.5 R&D Systems Key News
7.3 Lifespan Biosciences
  7.3.1 Lifespan Biosciences Corporate Summary
  7.3.2 Lifespan Biosciences Business Overview
  7.3.3 Lifespan Biosciences EPAS1 Antibody Major Product Offerings
  7.3.4 Lifespan Biosciences EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.3.5 Lifespan Biosciences Key News
7.4 Bio-Rad
  7.4.1 Bio-Rad Corporate Summary
  7.4.2 Bio-Rad Business Overview
  7.4.3 Bio-Rad EPAS1 Antibody Major Product Offerings
  7.4.4 Bio-Rad EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.4.5 Bio-Rad Key News
7.5 Abbexa Ltd
  7.5.1 Abbexa Ltd Corporate Summary
  7.5.2 Abbexa Ltd Business Overview
  7.5.3 Abbexa Ltd EPAS1 Antibody Major Product Offerings
  7.5.4 Abbexa Ltd EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.5.5 Abbexa Ltd Key News
7.6 Boster Bio
  7.6.1 Boster Bio Corporate Summary
  7.6.2 Boster Bio Business Overview
  7.6.3 Boster Bio EPAS1 Antibody Major Product Offerings
  7.6.4 Boster Bio EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.6.5 Boster Bio Key News
7.7 Atlas Antibodies
  7.7.1 Atlas Antibodies Corporate Summary
  7.7.2 Atlas Antibodies Business Overview
  7.7.3 Atlas Antibodies EPAS1 Antibody Major Product Offerings
  7.7.4 Atlas Antibodies EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.7.5 Atlas Antibodies Key News
7.8 Biobyt
  7.8.1 Biobyt Corporate Summary
  7.8.2 Biobyt Business Overview
  7.8.3 Biobyt EPAS1 Antibody Major Product Offerings
  7.8.4 Biobyt EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.8.5 Biobyt Key News
7.9 Novus Biologicals
  7.9.1 Novus Biologicals Corporate Summary
  7.9.2 Novus Biologicals Business Overview
  7.9.3 Novus Biologicals EPAS1 Antibody Major Product Offerings
  7.9.4 Novus Biologicals EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.9.5 Novus Biologicals Key News
7.10 Aviva Systems Biology
  7.10.1 Aviva Systems Biology Corporate Summary
  7.10.2 Aviva Systems Biology Business Overview
  7.10.3 Aviva Systems Biology EPAS1 Antibody Major Product Offerings
  7.10.4 Aviva Systems Biology EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.10.5 Aviva Systems Biology Key News
7.11 ProSci
  7.11.1 ProSci Corporate Summary
  7.11.2 ProSci Business Overview
  7.11.3 ProSci EPAS1 Antibody Major Product Offerings
  7.11.4 ProSci EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.11.5 ProSci Key News
7.12 BioLegend
  7.12.1 BioLegend Corporate Summary
  7.12.2 BioLegend Business Overview
  7.12.3 BioLegend EPAS1 Antibody Major Product Offerings
  7.12.4 BioLegend EPAS1 Antibody Revenue in Global Market (2017-2022)
  7.12.5 BioLegend Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. EPAS1 Antibody Market Opportunities & Trends in Global Market
Table 2. EPAS1 Antibody Market Drivers in Global Market
Table 3. EPAS1 Antibody Market Restraints in Global Market
Table 4. Key Players of EPAS1 Antibody in Global Market
Table 5. Top EPAS1 Antibody Players in Global Market, Ranking by Revenue (2021)
Table 6. Global EPAS1 Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global EPAS1 Antibody Revenue Share by Companies, 2017-2022
Table 8. Global Companies EPAS1 Antibody Product Type
Table 9. List of Global Tier 1 EPAS1 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 EPAS1 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global EPAS1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - EPAS1 Antibody Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - EPAS1 Antibody Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global EPAS1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - EPAS1 Antibody Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - EPAS1 Antibody Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global EPAS1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global EPAS1 Antibody Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global EPAS1 Antibody Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America EPAS1 Antibody Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America EPAS1 Antibody Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe EPAS1 Antibody Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe EPAS1 Antibody Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia EPAS1 Antibody Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia EPAS1 Antibody Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America EPAS1 Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America EPAS1 Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa EPAS1 Antibody Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa EPAS1 Antibody Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific EPAS1 Antibody Product Offerings
Table 32. Thermo Fisher Scientific EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 33. R&D Systems Corporate Summary
Table 34. R&D Systems EPAS1 Antibody Product Offerings
Table 35. R&D Systems EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 36. Lifespan Biosciences Corporate Summary
Table 37. Lifespan Biosciences EPAS1 Antibody Product Offerings
Table 38. Lifespan Biosciences EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 39. Bio-Rad Corporate Summary
Table 40. Bio-Rad EPAS1 Antibody Product Offerings
Table 41. Bio-Rad EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 42. Abbexa Ltd Corporate Summary
Table 43. Abbexa Ltd EPAS1 Antibody Product Offerings
Table 44. Abbexa Ltd EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 45. Boster Bio Corporate Summary
Table 46. Boster Bio EPAS1 Antibody Product Offerings
Table 47. Boster Bio EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 48. Atlas Antibodies Corporate Summary
Table 49. Atlas Antibodies EPAS1 Antibody Product Offerings
Table 50. Atlas Antibodies EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 51. Biobyt Corporate Summary
Table 52. Biobyt EPAS1 Antibody Product Offerings
Table 53. Biobyt EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 54. Novus Biologicals Corporate Summary
Table 55. Novus Biologicals EPAS1 Antibody Product Offerings
Table 56. Novus Biologicals EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 57. Aviva Systems Biology Corporate Summary
Table 58. Aviva Systems Biology EPAS1 Antibody Product Offerings
Table 59. Aviva Systems Biology EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 60. ProSci Corporate Summary
Table 61. ProSci EPAS1 Antibody Product Offerings
Table 62. ProSci EPAS1 Antibody Revenue (US$, Mn), (2017-2022)
Table 63. BioLegend Corporate Summary
Table 64. BioLegend EPAS1 Antibody Product Offerings
Table 65. BioLegend EPAS1 Antibody Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. EPAS1 Antibody Segment by Type in 2021
Figure 2. EPAS1 Antibody Segment by Application in 2021
Figure 3. Global EPAS1 Antibody Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global EPAS1 Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global EPAS1 Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by EPAS1 Antibody Revenue in 2021
Figure 8. By Type - Global EPAS1 Antibody Revenue Market Share, 2017-2028
Figure 9. By Application - Global EPAS1 Antibody Revenue Market Share, 2017-2028
Figure 10. By Region - Global EPAS1 Antibody Revenue Market Share, 2017-2028
Figure 11. By Country - North America EPAS1 Antibody Revenue Market Share, 2017-2028
Figure 12. US EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 13. Canada EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe EPAS1 Antibody Revenue Market Share, 2017-2028
Figure 16. Germany EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 17. France EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 19. Italy EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Russia EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia EPAS1 Antibody Revenue Market Share, 2017-2028
Figure 24. China EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. Japan EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. India EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America EPAS1 Antibody Revenue Market Share, 2017-2028
Figure 30. Brazil EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa EPAS1 Antibody Revenue Market Share, 2017-2028
Figure 33. Turkey EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Israel EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. UAE EPAS1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. R&D Systems EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lifespan Biosciences EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bio-Rad EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbexa Ltd EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boster Bio EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Atlas Antibodies EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biobyt EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novus Biologicals EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Aviva Systems Biology EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ProSci EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. BioLegend EPAS1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)